Literature DB >> 196828

Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin.

J Asselin, P A Kelly, M G Caron, F Labrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 196828     DOI： 10.1210/endo-101-3-666

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  14 in total

1.  Physiological and cytogenetic characterization of immortalized human endometriotic cells containing episomal simian virus 40 DNA.

Authors:  A Akoum; J Lavoie; R Drouin; C Jolicoeur; A Lemay; R Maheux; E W Khandjian
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.

Authors:  R Poulin; D Baker; D Poirier; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Total prolactin binding sites in human breast cancer biopsies.

Authors:  J P Peyrat; D Dewailly; J Djiane; P A Kelly; B Vandewalle; J Bonneterre; J Lefebvre
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

4.  Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

Authors:  S Dauvois; S M Li; C Martel; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

5.  Prolactin binding by human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age.

Authors:  B Rae-Venter; T Nemoto; S L Schneider; T L Dao
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate.

Authors:  S Li; M Lepage; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins.

Authors:  Y E Shi; J Torri; L Yieh; M E Sobel; Y Yamada; M E Lippman; R B Dickson; E W Thompson
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

8.  Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.

Authors:  F Labrie; S Li; A Bélanger; J Côté; Y Mérand; M Lepage
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  Antiestrogen action of progesterone in breast tissue.

Authors:  P Mauvais-Jarvis; F Kuttenn; A Gompel
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

10.  Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.

Authors:  P G Spinola; B Marchetti; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.